Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia

Mult Scler. 2013 Aug;19(9):1238-9. doi: 10.1177/1352458512471881. Epub 2013 Jan 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Benzamides / therapeutic use*
  • Brain / pathology
  • Chronic Disease
  • Humans
  • Imatinib Mesylate
  • Leukemia / complications*
  • Leukemia / drug therapy*
  • Magnetic Resonance Imaging
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / complications*
  • Multiple Sclerosis, Relapsing-Remitting / pathology
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate